AFTER winning a prestigious award at an international cystic fibrosis conference, Stephen Stick says he would like to see steady funding for his research team.
“We’ve demonstrated we’re one of the best research teams in the world, so we want to see funding for our core activities,” Dr Stick said.
“The value of the award is it’s probably one of the top awards in the field for clinical research; it comes with endorsement from peers, patients, families and community.”
The US Cystic Fibrosis Foundation awarded Dr Stick a Richard C. Talamo Distinguished Clinical Achievement Award, one of the organisation’s highest honours.
Dr Stick was one of more than 3000 attendees at the annual conference in Phoenix, Arizona last month.
“This is a fantastic honour to be recognised by the world’s leading cystic fibrosis organisation and really demonstrates the pivotal role our research is playing in developing new treatments to help children with CF live longer, healthier lives,” he said.
Dr Stick said cystic fibrosis research had been one of the most exciting areas of medicine in 25 years.
The paediatrician came to Perth from England in 1987 and he has been Head of Respiratory Medicine at Princess Margaret Hospital since 1998.
“When the gene was discovered in 1989, it led to therapies to target those genes, leading to a personalised approach to medicine,” he said.
“The next wave of research occurred while I’ve been here and we’ve been at the cutting edge of developments.”
Dr Stick said his team was committed to reduce lung disease at six years of age by 50 per cent, which could extend the life expectancy of kids born with CF by 20 years.